Results 181 to 190 of about 106,787 (338)

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

Vitamin D and oral disease relationships: Insights from a bidirectional Mendelian randomization investigation. [PDF]

Medicine (Baltimore)
Shi Y, Li X, Chen B, Wang Y, Bai G.
europepmc   +1 more source

Between Aims and Execution: Value Trade-Offs in the Practical Implementation of the European Arrest Warrant? – ERRATUM

European Journal of Risk Regulation
Bjorn Kleizen, J. Wynen, Veronica Junjan
semanticscholar   +1 more source

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

Association between programmed electrical stimulation inducibility and arrhythmic risk in hypertrophic cardiomyopathy: a systematic review and meta-analysis. [PDF]

Heart
Salihu A, Antiochos P, Lu H, Maurizi N, Monney P, Pascale P.   +5 more
europepmc   +1 more source

Long‐term impact of Elexacaftor/Tezacaftor/ivacaftor on pulmonary, nutritional and metabolic outcomes in homozygous F508del cystic fibrosis patients: A real‐world cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aim Elexacaftor/tezacaftor/ivacaftor (ETI) has markedly improved cystic fibrosis (CF) outcomes. However, its long‐term impact on nutrition, metabolism and liver health remains underexplored. We assessed 30‐month changes in pulmonary, nutritional, metabolic and inflammatory markers in people with CF (PwCF) homozygous for F508del.
Nicola Perrotta, Luigi Angelo Fiorito, Roberta Vescovo, Anna Virgilio, Giulia Amato, Giuseppe Cimino   +5 more
wiley   +1 more source

Emergency medical services, treatment of cardiac arrest patients and cardiac arrest registries in Europe - Update on systems. [PDF]

Resusc Plus
Strömsöe A, Tjelmeland IBM, Masterson S.   +2 more
europepmc   +1 more source

EUROPEAN ARREST WARRANT IN THE SYSTEM OF LAW ENFORCEMENT ACTIVITIES

Juridical scientific and electronic journal
S. Davydenko, D.I. Demchenko
semanticscholar   +1 more source

Buffalo chest after minimally invasive repair of pectus excavatum for pectus excavatum: results of the Chest Wall International Group (CWIG) survey. [PDF]

J Thorac Dis
Donati F, Martinez-Ferro M, Lopez M, Torre M.   +3 more
europepmc   +1 more source

Private Defence and Public Defence in the Criminal Law and in the Law of Tort—A Comparison'. [PDF]

, 2012
Andoh, Benjamin, Parsons, Simon
core   +2 more sources